A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

BI 1467335 NASH Phase IIa trial team

Research output: Contribution to journal › Article › peer-review

19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences

Chemistry